ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Role, Issues In Education Considered By DRCCA Board

August 21, 1981

Chemotherapy After Surgery Extends Survival By 32%

January 27, 2006

RFPs Available, NIH Funding Strategies

February 18, 1994

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

Robert Hall appointed government relations director for National Coalition for Cancer Survivorship.

April 30, 2004